Industry reports
Editor highlights

Search inside this page

All regions

Free Market Research Guides to Download

Biotechnology Analysis & Statistics in the United States, August 2011 (p20)

You might be interested in: biotech, biomedical, protein, more »

» Purchase Premium Reports

571-600 of about 900 reports
Actelion Ltd SWOT

Actelion Ltd SWOT

  • $ 175
  • Company report
  • August 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Actelion is a biopharmaceutical industry player focused ...

  • Industries : Biopharmaceutical
  • Countries : Switzerland, Australia, Brazil, Canada, Japan, World, Europe, United States
Micromet, Inc.- Strategy and SWOT Report

Micromet, Inc.- Strategy and SWOT Report

  • $ 175
  • Company report
  • July 2011
  • by MarketLine

Micromet, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings ...

  • Industries : Biopharmaceutical
  • Countries : United States
Pfizer Inc. SWOT

Pfizer Inc. SWOT

  • $ 175
  • Company report
  • July 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Pfizer is the world's premier biopharmaceutical industry ...

  • Industries : Biopharmaceutical
  • Countries : United States
Micromet, Inc. SWOT

Micromet, Inc. SWOT

  • $ 175
  • Company report
  • July 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Micromet is a biopharmaceutical industry player focused ...

  • Industries : Biopharmaceutical
  • Countries : United States
Next Generation Sequencing Generates Momentum: Markets Respond to Technology and Innovation Advances - Overview

Next Generation Sequencing Generates Momentum: Markets Respond to Technology and Innovation Advances - Overview

  • $ 3 195
  • Industry report
  • July 2011
  • by CHI Insight Pharma Reports

This report focuses on current and innovative NGS technologies, services and markets to answer such questions as; Which early NGS market entrants have been continually improving and updating thei ...

  • Industries : Genomics
  • Countries : United States
Engineering Next-Generation Therapeutic Proteins: Trends and Markets To 2020 - Overview

Engineering Next-Generation Therapeutic Proteins: Trends and Markets To 2020 - Overview

  • $ 3 195
  • Industry report
  • July 2011
  • by CHI Insight Pharma Reports

By 2020, the current renaissance of biotechnology will have resulted in a broad range of products that will, almost without exception, involve a degree of protein engineering. This report discusses new ...

  • Industries : Biopharmaceutical
  • Countries : United States
Next-Generation Mass Spectrometry: Technology Advances and Applications - Overview

Next-Generation Mass Spectrometry: Technology Advances and Applications - Overview

  • $ 595
  • Industry report
  • July 2011
  • by CHI Insight Pharma Reports

Advances in biomedical instrumentation are enabling a new perspective that could not have been achieved even a decade ago. Mass spectrometry is the most significant and far reaching of these developments, ...

  • Industries : Genomics
  • Countries : United States
Cosmeceuticals Industry

Cosmeceuticals Industry

  • $ 4 900
  • Industry report
  • July 2011
  • by Freedonia

US demand to rise 5.8% annually through 2015 US demand for cosmeceutical products is expected to increase 5.8 percent per annum to $8.5 billion in 2015, driven by an increasingly competitive employment ...

  • Industries : Biomaterial
  • Countries : United States
US Cosmeceuticals Market: Focus report

US Cosmeceuticals Market: Focus report

  • $ 600
  • Industry report
  • July 2011
  • by Freedonia Focus

Report Description This report discusses US cosmeceuticals for the years 2005 and 2010, with forecasts for 2015. Topics covered include market size, product and chemical segmentation, regulatory considerations, ...

  • Industries : Biomaterial
  • Countries : United States
Biological Therapy Industry: Behcet%s Disease - Pipeline Review, Q2 2011

Biological Therapy Industry: Behcet%s Disease - Pipeline Review, Q2 2011

  • $ 500
  • Industry report
  • June 2011
  • by Global Markets Direct

Behcet's Disease - Pipeline Review, Q2 2011 What's inside this report? Global Industry s Direct's, 'Behcet's Disease - Pipeline Review, Q2 2011', provides an overview of the Behcet's Disease therapeutic ...

  • Industries : Biological Therapy
  • Countries : United States, World
Kane Biotech Inc. (Symbol:KNE) SWOT Analysis, Strategy, Revenues and Profits

Kane Biotech Inc. (Symbol:KNE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : United States, Canada
Alliqua, Inc. (Symbol:HPLF) SWOT Analysis, Strategy, Revenues and Profits

Alliqua, Inc. (Symbol:HPLF) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • May 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
AdvanSource Biomaterials Corporation (Symbol:ASB) SWOT Analysis, Strategy, Revenues and Profits

AdvanSource Biomaterials Corporation (Symbol:ASB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biomaterial
  • Countries : United States
Genomic Sequencing Technologies for Medicine: Market Prospects 2011-2021

Genomic Sequencing Technologies for Medicine: Market Prospects 2011-2021

  • $ 2 313
  • Industry report
  • May 2011
  • by Visiongain

How you can discover commercial opportunities in genomics How will the genomic sequencing market develop this decade? Our new report shows you that industry and market's revenue potential from 2011 to ...

  • Industries : Genomics
  • Countries : World, United States
The Coming Age of Biosimilars - Regulatory developments and alliance strategies intensify interest in a developing market

The Coming Age of Biosimilars - Regulatory developments and alliance strategies intensify interest in a developing market

  • $ 3 900
  • Industry report
  • May 2011
  • by CBR Pharma Insights

Biosimilars are attracting significant attention at present as companies from all sectors of the biopharmaceutical market are investigating the opportunities they present. Opinion is split as to the true ...

  • Industries : Biopharmaceutical
  • Countries : Europe, World, United States
BioTime, Inc. (Symbol:BTIM) SWOT Analysis, Strategy, Revenues and Profits

BioTime, Inc. (Symbol:BTIM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Millipore Corporation (Symbol:MIL) SWOT Analysis, Strategy, Revenues and Profits

Millipore Corporation (Symbol:MIL) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, Canada, Germany
InNexus Biotechnology Inc. (Symbol:IXS) SWOT Analysis, Strategy, Revenues and Profits

InNexus Biotechnology Inc. (Symbol:IXS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : Canada, United States
Commercializing Biomarkers in Therapeutic and Diagnostic Applications - Overview

Commercializing Biomarkers in Therapeutic and Diagnostic Applications - Overview

  • $ 3 195
  • Industry report
  • May 2011
  • by CHI Insight Pharma Reports

Biomarkers feature in thousands of published articles each year, evidencing the high level of interest and research in this field. This report focuses on issues that must be addressed to utilize this growing ...

  • Industries : Genomics
  • Countries : United States
What%s Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015

What%s Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015

  • $ 3 995
  • Industry report
  • May 2011
  • by Kalorama Information

The future of the pharmaceutical market will be determined by biologics - drugs produced by natural organisms or recombinant techniques consisting of proteins and other products derived from living organisms ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Biological Therapy Industry: Indolent Lymphoma - Pipeline Review, Q2 2011

Biological Therapy Industry: Indolent Lymphoma - Pipeline Review, Q2 2011

  • $ 500
  • Company report
  • April 2011
  • by Global Markets Direct

This report provides data on the therapeutic development for Indolent Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Biological Therapy
  • Countries : United States
Legal Services Industry: ZymoGenetics, Inc. - Strategy and SWOT Report

Legal Services Industry: ZymoGenetics, Inc. - Strategy and SWOT Report

  • $ 175
  • Company report
  • April 2011
  • by MarketLine

Datamonitors' ZymoGenetics, Inc.?s SWOT, Strategy and Corporate Finance Report, is a source of comprehensive industry player data and information. The market research report covers the firm ?s structure, ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biopharmaceutical in United States: Company Financials: Vical Incorporated

Biopharmaceutical in United States: Company Financials: Vical Incorporated

  • $ 75
  • Industry report
  • April 2011
  • by Datamonitor

About This Report The Firms Financials offers insights into the financial performance of the industry player over last five years for about 1000 leading global firms . The datapack covers wealth of financial ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biopharmaceutical in United States: Company Financials: XenoPort, Inc.

Biopharmaceutical in United States: Company Financials: XenoPort, Inc.

  • $ 75
  • Industry report
  • April 2011
  • by Datamonitor

About This Report The Firms Financials offers insights into the financial performance of the industry player over last five years for about 1000 leading global firms . The datapack covers wealth of financial ...

  • Industries : Biopharmaceutical
  • Countries : United States
US Stem Cell Market Analysis

US Stem Cell Market Analysis

  • $ 800
  • Industry report
  • April 2011
  • by RNCOS

The stem cell market has been growing at a fast pace for the past few years and despite recession, the US continued to witness positive developments and massive investments in this industry. Using stem ...

  • Industries : Biological Therapy
  • Countries : United States
ZymoGenetics, Inc. SWOT

ZymoGenetics, Inc. SWOT

  • $ 175
  • Company report
  • April 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. ZymoGenetics, a wholly-owned subsidiary of Bristol-Myers ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biomaterials that Deliver Antimicrobials: An Overview

Biomaterials that Deliver Antimicrobials: An Overview

  • $ 500
  • Industry report
  • March 2011
  • by Global Data

The report provides key industry ed products, key players and industry dynamics. The report provides comprehensive data on the industry drivers and restraints affecting the industry growth. Scope of the ...

  • Industries : Biomaterial
  • Countries : United States
Biopharmaceutical Industry: Keryx Biopharmaceuticals, Inc. ? Product Pipeline Review - Q1 2011

Biopharmaceutical Industry: Keryx Biopharmaceuticals, Inc. ? Product Pipeline Review - Q1 2011

  • $ 500
  • Company report
  • March 2011
  • by Global Markets Direct

- Product Pipeline Review - Q1 2011? provides a detailed overview on the firm ?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - Q1 2011

Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - Q1 2011

  • $ 500
  • Company report
  • March 2011
  • by Global Markets Direct

- Product Pipeline Review - Q1 2011? provides a detailed overview on the firm ?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market

Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market

  • $ 3 500
  • Industry report
  • March 2011
  • by GBI Research

Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market Summary GBI Research's report, ?Upstream Processing in Biopharmaceuticals ...

  • Industries : Biopharmaceutical
  • Countries : United States, Japan, India

» View Public Reports

About 2 400 reports

U.S. Genomics Business

  • Industry report
  • March 2014
  • 32 pages
  • by Research Paper

... Asia (91), africa (35), south america (9) and central america (47) were evaluated at genetic and phenotypic level to find genetic variation and important traits for oilseed production. Results ...


» Read our Company Profiles

22 Companies

Johnson and Johnson

United States

GlaxoSmithKline P.L.C.

United States

Biogen Idec

United States

Abbott Laboratories

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.